Complicated Urinary Tract Infection Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Allecra Therapeutics, Merck Sharp & Dohme, …

In January 2025, Wockhardt announced that ZAYNICH demonstrated unprecedented efficacy in a global, pivotal Phase III study ...
FiercePharma

U.S. Pharmaceutical Company Merck Sharp & Dohme to Pay Nearly One Billion Dollars Over Promotion of Vioxx®

WASHINGTON - American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal charges and civil claims related to its promotion and marketing of the painkiller ...
WALB on MSN

WALB Investigates: Merck moves to dismiss Flint River Plant cancer lawsuit

WALB Investigates Team received the motion filed Oct. 29, 2025, Merck Co. is asking a Georgia court to dismiss a lawsuit tied ...
Reuters

Merck sees sharp decline in COVID sales for 2023 after strong fourth quarter

Feb 2 (Reuters) - Merck & Co (MRK.N), opens new tab on Thursday forecast 2023 earnings below Wall Street estimates along with an expected steep decline in sales of its COVID-19 antiviral treatment, ...
FiercePharma

After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound

Despite a rocky start to the year for Merck KGaA’s contract development and manufacturing group, the German company is finding some reason to be optimistic about its recent performance. Last week, ...
c-span

Merck Sharp and Dohme Corporation v. Albrecht Oral Argument

2019-01-11T20:00:21-05:00https://ximage.c-spanvideo.org ...